单疱病毒角膜炎是一种常见的致盲率较高的传染性眼病。本病类型多样,病情常迁延不愈,多有复发趋势,且多发于青壮年,严重损害视力,对学习与工作有很大的影响。半个世纪以来,经过全世界科学家的共同努力,本病治疗学日新月异,有了很大的发展。疗法众多,有物理、化学对病变上皮的清除疗法,霉类清除病灶疗法,光灭活疗法,手术疗法,中草药疗法,抗代谢疗法和较新的免疫疗法。其中对抗代谢疗法有较多的研究和成效。1962年 Kaufman 首次引用 IDU 治疗本病,以后氟胸腺嘧啶核甙、阿糖胞甙、阿糖腺甙和环胞甙又相继用来治疗本病,取得较好的疗效。但也存在一系列问题,如耐药菌株的出现,药物抑制了机体的免疫反应,促使角膜炎的复发,这类药物对角膜有一定的毒性反应等。因此,寻找 Herpes simplex virus keratitis is a common blinding rate of infectious eye disease. Diverse types of the disease, the disease often delayed unhealed, and more recurrence trends, and multiple in young adults, seriously damaging the vision, the study and work have a great impact. Half a century, through the joint efforts of scientists from all over the world, the treatment of this disease with each passing day, with great development. There are numerous therapies, physical and chemical clearance of diseased epithelium, mycotic dehiscence therapy, photoinactivation therapy, surgical therapy, herbal remedies, anti-metabolic therapies and newer immunotherapies. Among them, there are more research and results on anti-metabolism therapy. 1962 Kaufman first reference IDU treatment of the disease, after fluorine fluorothymidine, cytarabine, glycosides and cyclophoside have been used to treat the disease, and achieved good results. But there are also a series of problems, such as the emergence of drug-resistant strains, the drug inhibits the body’s immune response, prompting the recurrence of keratitis, such drugs have some toxicity to the cornea. So look for it